<DOC>
	<DOCNO>NCT01112579</DOCNO>
	<brief_summary>The purpose study determine feasibility spinal cord stimulation ( SCS ) chronic therapy systolic heart failure .</brief_summary>
	<brief_title>Determining Feasibility Spinal Cord Neuromodulation Treatment Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Left Ventricular Ejection Fraction ( LVEF ) 35 percent less New York Heart Association ( NYHA ) functional Class III time screen QRS duration le 120 millisecond ( m ) Left Ventricular End Diastolic Diameter ( LVEDD ) 55 millimeter ( mm ) 80 mm determine echocardiography within past 6 month Receiving stable optimal medical therapy heart failure prior enrollment Serum creatinine less equal 3.0 milligram per deciliter ( mg/dL ) 18 year age old Willing able comply study procedure Expected lifespan great 12 month beyond study enrollment assess physician Interruption thromboprophylaxis ( e.g. , heparin , LMWH , warfarin , aspirin , dabigatran , clopidogrel ) would pose unacceptable health risk ( e.g. , patient abnormal bleeding time ) , determine physician Polyneuropathy Requires diathermy include shortwave diathermy , microwave diathermy , therapeutic ultrasound diathermy Unable perform exercise capacity test Pregnant planning become pregnant study Currently enrol plan enroll another investigational device drug study may confound result study Had Coronary Artery Bypass Graft/Percutaneous Coronary Intervention/Bare Metal Stent ( CABG/PCI/BMS ) procedure within past 90 day Had heart transplant Has complete heart block Had Acute Coronary Syndrome within past 90 day Has congenital heart disease significant hemodynamic shunting Has chemotherapyinduced heart failure Has reversible cardiomyopathy Has severe mitral regurgitation ( great 60 percent regurgitant fraction great 0.3 centimeter square ( cm2 ) regurgitant orifice area ) Has diagnose unstable angina pectoris Has unstable coronary artery disease Has Cardiac Resynchronization Therapy ( CRT ) device implant receive CRT therapy Has nonMedtronic Implantable Cardioverter Defibrillator ( ICD ) , pacemaker , nontransvenous defibrillation lead Has Medtronic ICD whose sense threshold program 0.3mV great Has exist neurostimulator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>